Research

Remote patient care is one of the fastest-growing areas in healthcare. Using remote patient monitoring monitoring for stroke recovery, includes wearable devices with sensors and biosensors to track patient health data continuously, outside traditional clinical settings. For stroke survivors, that continuous window matters: recovery and the risk of a second stroke play out over weeks […]

The healthcare landscape is rapidly evolving, driving an unprecedented demand for scalable, high-quality care outside the traditional hospital setting. For remote patient monitoring (RPM) software and service companies, chronic care management (CCM) organizations, and telehealth providers, demonstrating clinical efficacy is essential for growth. Delivering reliable remote patient monitoring for patients is no longer just about

With the extension of the Acute Hospital Care at Home (AHCaH) waiver through 2030, healthcare systems are scaling home-based recovery programs. To understand the drivers of patient compliance in remote care, we can look at the findings from Vivalink’s 2026 Acute Patient RPM Survey, which polled patients managing severe conditions like cancer and cardiac disease.

The acute hospital at home (HaH) program is a healthcare model where patients receive acute care services in their homes rather than in a traditional hospital setting.  The Centers for Medicare & Medicaid Services launched the Acute Hospital Care At Home program in November 2020, to give hospitals expanded flexibility to care for patients in

Recent research highlights the profound impact of remote patient monitoring (RPM) technology on hospital readmission rates for cardiac patients. By examining data from two pivotal studies, it becomes clear how telemedicine and remote monitoring solutions actively work to improve patient outcomes while significantly reducing the burden on our healthcare systems. Tackling the High Hospital Readmission

Continuous physiological monitoring has become a cornerstone in advancing patient care, particularly through wearable technologies that offer real-time insights into vital signs. This article examines research into continuous physiological monitoring. Drawing from a large-scale observational study published in the Journal of Clinical Medicine, we explore how the BioIntelliSense BioButton®, an FDA-cleared device, supports clinical decisions